Title: Protecting oral health in children with acute lymphoblastic leukemia undergoing chemotherapy
Abstract:
Background: Acute Lymphoblastic Leukemia (ALL) is the most common childhood malignancy, accounting for nearly 30% of pediatric cancers. While survival rates have improved significantly, chemotherapy often leads to oral complications that negatively affect quality of life.
Methods: This study included 34 children (aged 2–14 years) diagnosed with ALL. Clinical oral examinations were conducted using OHI-S, Plaque Index, Gingival Index, and deft/DMFT indices. Preventive oral care, including professional prophylaxis and fluoride application, was provided before, during, and after chemotherapy.
Results: The mean age was 7.70 ± 3.03 years. Following chemotherapy, 91.2% of patients developed oral complications, including dental caries (55.9%), tooth sensitivity (32.4%), and gingival problems (2.9%). Preventive fluoride therapy resulted in improvement in 74% of patients, including arrest of caries progression and reduction in sensitivity. However, 26% showed no improvement (P > 0.05).
Conclusion: Oral complications are highly prevalent in children with ALL undergoing chemotherapy. Preventive strategies, particularly fluoride therapy and regular monitoring, play a vital role in improving oral health outcomes and should be integrated into comprehensive cancer care.


